The association between phenotypes of polycystic ovary syndrome and metabolic dysfunction-associated fatty liver disease.

ABSTRACT:

Introduction

Polycystic ovary syndrome (PCOS) is associated with an increased risk of non-alcoholic fatty liver disease (NAFLD). With the introduction of the new definition of metabolic dysfunction-associated fatty liver disease (MAFLD), there has been a lack of studies investigating the prevalence and clinical characteristics of PCOS and its phenotypes, including hyperandrogenism (HA), oligoanovulation (OA), and polycystic ovarian morphology (PCO) in association with MAFLD. The aim of this study is to explore MAFLD prevalence in young women with PCOS and determine the independent impact of PCOS phenotypes on MAFLD.

Methods

This cross-sectional study included 1,422 women with PCOS diagnosed using the Rotterdam criteria, the presence of at least two of three diagnostic criter

SUBMITTER: Hong SH 

PROVIDER: S-EPMC12358263 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature